Penumbra, Inc (PEN) Gross Margin
- Gross margin · 12 months: Value 67.84%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 67.84% | Gross profit / revenue. Period ending 2026-06-30. $1.02B ÷ $1.50B × 100 ≈ 67.84% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 1.02B USD | Gross Profit |
| Revenue | 1.50B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $1.02B | $1.50B | (m) | 67.84% |
| 2026-03-31 | $979.97M | $1.45B | (m) | 67.38% |
| 2025-12-31 | $942.44M | $1.40B | (m) | 67.14% |
| 2025-09-30 | $891.03M | $1.33B | (m) | 66.80% |
| 2025-06-30 | $850.92M | $1.28B | (m) | 66.47% |
| 2025-03-31 | $789.74M | $1.24B | (m) | 63.68% |
| 2024-12-31 | $755.00M | $1.19B | (m) | 63.20% |
| 2024-09-30 | $731.27M | $1.16B | (m) | 62.84% |
| 2024-06-30 | $708.68M | $1.13B | (m) | 62.51% |
| 2024-03-31 | $712.71M | $1.10B | (m) | 65.04% |
| 2023-12-31 | $682.64M | $1.06B | (m) | 64.49% |
| 2023-09-30 | $634.08M | $995.06M | (m) | 63.72% |
| 2023-06-30 | $591.69M | $937.79M | (m) | 63.09% |
| 2023-03-31 | $558.86M | $884.64M | (m) | 63.17% |
| 2022-12-31 | $535.21M | $847.13M | (m) | 63.18% |
| 2022-09-30 | $522.23M | $829.93M | (m) | 62.92% |
| 2022-06-30 | $506.81M | $806.37M | (m) | 62.85% |
| 2022-03-31 | $491.46M | $782.28M | (m) | 62.82% |
| 2021-12-31 | $475.38M | $747.59M | (m) | 63.59% |
| 2021-09-30 | $444.25M | $710.48M | (m) | 62.53% |
| 2021-06-30 | $415.26M | $671.44M | (m) | 61.85% |
| 2021-03-31 | $361.50M | $592.29M | (m) | 61.04% |
| 2020-12-31 | $338.18M | $560.41M | (m) | 60.34% |
| 2020-09-30 | $341.99M | $538.78M | (m) | 63.48% |
| 2020-06-30 | $347.06M | $527.20M | (m) | 65.83% |
| 2020-03-31 | $376.06M | $556.29M | (m) | 67.60% |
| 2019-12-31 | $371.96M | $547.40M | (m) | 67.95% |
| 2019-09-30 | $352.55M | $522.93M | (m) | 67.42% |
| 2019-06-30 | $331.56M | $495.24M | (m) | 66.95% |
| 2019-03-31 | $309.89M | $470.68M | (m) | 65.84% |
| 2018-12-31 | $292.53M | $444.94M | (m) | 65.75% |
| 2018-09-30 | $277.55M | $420.20M | (m) | 66.05% |
| 2018-06-30 | $257.31M | $392.30M | (m) | 65.59% |
| 2018-03-31 | $235.99M | $363.25M | (m) | 64.97% |
| 2017-12-31 | $217.14M | $333.76M | (m) | 65.06% |
| 2017-09-30 | $200.00M | $310.82M | (m) | 64.34% |
| 2017-06-30 | $188.09M | $294.09M | (m) | 63.96% |
| 2017-03-31 | $178.63M | $278.61M | (m) | 64.12% |
| 2016-12-31 | $170.83M | $263.32M | (m) | 64.88% |
| 2016-09-30 | $160.71M | $244.63M | (m) | 65.69% |
| 2016-06-30 | $151.33M | $227.86M | (m) | 66.41% |
| 2016-03-31 | $137.24M | $205.06M | (m) | 66.92% |
| 2015-12-31 | $124.06M | $186.09M | (m) | 66.66% |
| 2015-09-30 | (m) | (m) | (m) | (m) |
| 2015-06-30 | $98.79M | $149.13M | (m) | 66.24% |
| 2015-03-31 | $92.12M | $138.30M | (m) | 66.61% |
| 2014-12-31 | $82.84M | $125.51M | (m) | 66.00% |
| 2014-09-30 | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) |
| 2013-12-31 | $57.88M | $88.85M | (m) | 65.14% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |